{"brief_title": "Study to Evaluate Frozen Versus Refrigerated MMRV (Combined Measles, Mumps, Rubella, and Varicella) Investigational Vaccine (V221-016)", "brief_summary": "The purpose of this study is to demonstrate that an investigational refrigerated vaccine with measles, mumps, rubella, and varicella is well tolerated and has similar immune response when compared to a frozen vaccine with measles, mumps, rubella, and varicella.", "condition": "Varicella", "intervention_type": "Biological", "intervention_name": "V221, measles, mumps, rubella and varicella (Oka/Merck) virus vaccine live / Duration of Treatment: 12 weeks", "criteria": "Inclusion Criteria: - Healthy children 12-23 months of age Exclusion Criteria: - Previously had measles, mumps, rubella, or varicella - Compromised immune system", "gender": "All", "minimum_age": "12 Months", "maximum_age": "23 Months", "healthy_volunteers": "Accepts Healthy Volunteers", "id": "NCT00092430.xml"}